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Members of the G,, subfamily of heterotrimeric  gua- 
nine nucleotide-binding proteins (G proteins) activate 
phospholipase C (PLC). The complementary DNAs 
(cDNAs) for  the G protein a subunits G,, and G11, were 
expressed  in insect (Sf9) cells using recombinant bac- 
ulovirus. Active, nonaggregated, and membrane-asso- 
ciated  protein  was  generated only when the a subunit 
cDNA was  expressed  together  with cDNAs encoding G 
protein B and  subunits. Recombinant a subunits (rGqa 
and rGll,) were  purified by three-step  procedures, as 
was a PLC-activating a subunit(s) endogenous to Sf9 
cells. Guanosine 5'-3-(thio)triphosphate  (GTPrS)  ac- 
tivated rG, and rGll, with an  apparent Ko.5 of 30 NM; 
similarly high concentrations of the nucleotide were 
required  to  observe ['"SIGTPrS binding  to rGqa. Acti- 
vated rG,, and rGll, each  stimulated  all three isoforms 
of purified PLC-B with the  rank  order of potency PLC- 
B 1 =  PLC-83 2 PLC-B2; both a subunits also stimulated 
PLC-B1 and PLC-j33 to a much greater  extent (10-fold) 
than they  did PLC-62. In contrast,  activated rG,, and 
rGll, failed to stimulate either PLC-61 or PLC-71. 
Recombinant GSal, GL2,  Gi-3, GOP(*), G and G, all failed 
to  stimulate  any of the isoforms of PLC. The  apparent 
affinities of rG,, and  rGll,  for PLC-B1 and  their ca- 
pacities  to  activate the enzyme were  similar  to values 
observed for  purified brain Gqa,ll,. Purified  brain ,& 
subunits also stimulated  the three isoforms of PLC-8. 
The  capacities of rG,, and rGll, to  activate PLC-B1 
and PLC-83 greatly exceeded those of Br, whereas G,,, 
G11, and By were  roughly equiefficacious with PLC- 
02; the a subunits were more potent than  in  all cases. 
The  effects of a and Br together  were  nonadditive  for 
both PLC-B1 and PLC-82. These results  demonstrate 
that G,, and GI1, specifically and selectively stimulate 
B isoforms of PLC and confirm the idea that these 
members of the G,, subfamily of G proteins are phys- 
iological regulators of this  signaling  pathway. 
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Heterotrimeric guanine nucleotide-binding regulatory pro- 
teins  (G  proteins)' serve an essential role in cell physiology 
by transducing signals from a broad class of cell surface 
receptors to specific effector proteins at  the plasma membrane 
(1-5). G  protein  subunits  are designated a (39-46 kDa), /3 (37 
kDa),  and y (8 kDa),  and  to date, at least 21 unique a, 4 /3, 
and  6 y subunits have been identified (2,5). Some of these  G 
proteins  are known to regulate specific effectors in response 
to activation by defined receptors. For example, G. and Golf 
activate isozymes of adenylylcyclase (1,6); Gtl and G,, activate 
cGMP-specific phosphodiesterases in  retinal rods and cones 
(7); and G,, Gil, Gi2, Gi3, and Go can modulate the activity of 
certain ion channels (8). 
A wide variety of neurotransmitters, hormones, and growth 
factors activates  PLC to hydrolyze the membrane lipid phos- 
phatidylinositol 4,5-bisphosphate and thereby generate two 
second messengers, Ins(1,4,5)P3 and diacylglycerol (9, 10). 
Compelling evidence indicates a role for one or more G 
protein(s) in this signaling pathway (11, 12). In a limited 
number of cells, receptor-mediated activation of PLC is in- 
hibited by prior  treatment with pertussis toxin, suggesting a 
role for a  protein of the Gi or Go type. However, in most cells 
regulation of PLC by G proteins is insensitive to bacterial 
toxins.  Eight  G  protein a subunits that are  not  substrates for 
ADP-ribosylation by bacterial toxins have been identified 
recently, either by molecular cloning (13-17) or biochemically 
(18-21). These include members of the G, subfamily (G,, Gll, 
GM, GI5, GIG), the Glz subfamily (GI*  and G1& and G, (2, 5). 
Recent reports also indicate that  at least some members of 
the G, subfamily can  stimulate  PLC activity (21-25). A mix- 
ture of  G,, and Gll, has been purified from  bovine brain  (19) 
and rat liver (20); a closely related protein has also been 
isolated from turkey  erythrocytes (21). Reconstitution of 
these  activated  proteins with purified mammalian PLC-pl or 
turkey  erythrocyte  PLC markedly stimulates enzymatic activ- 
ity (21-23). Nevertheless, the close structural similarities 
between G,, and Gll, (88% amino acid identity) make their 
biochemical resolution difficult (19, 20, 26). Strathmann  and 
Simon (13) isolated the full-length cDNAs for both G,, and 
G11,; these have been expressed in mammalian cells and 
shown to encode proteins that activate PLC-p1 (27). To 
obtain pure, resolved G,, and Gll, for functional studies  and 
biochemical characterization, we have synthesized these  pro- 
' The abbreviations used are: G protein(s), heterotrimeric guanine 
nucleotide-binding regulatory protein(s); G,, the (Y subunit of a G 
protein; GTPrS, guanosine 5'-3-0-(thio)triphosphate; PLC, phos- 
pholipase C; PLC-@, -7, and -6, the 8, 7, and 6 isoforms of PLC; 
Inspa, inositol trisphosphate; PIP2, phosphatidylinositol bisphos- 
phate. 
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14368 Recombinant Gga and GI1, 
teins in Sf9 insect cells using a baculovirus  expression system. 
We now describe the purification and characterization of 
these proteins  and  their  capacity to activate different  purified 
isoforms of PLC. 
MATERIALS AND  METHODS 
Construction of G,, and G,,, Transfer Vectors-All methods used 
to construct the plasmids for expression of G  protein a subunits have 
been described by Sambrook et al. (28). An Sf9 insect cell/baculovirus 
expression system (29) was used; the pVL1393  or  pVL1392 transfer 
vector containing  a polyhedron promoter and  an ampicillin resistance 
gene  was chosen for expressionpurposes.  Full-length cDNAs encoding 
rG,, and rGll, were generated as described (13). To construct the 
expression vector for rG,,, pVL1393 was cleaved with BamHI and 
SmaI; the G,, cDNA  was cleaved with BamHI and Ssp1 to yield a 
1.2-kilobase fragment containing the  entire coding sequence. The G,, 
fragment was purified by gel electrophoresis, ligated with digested 
pVL1393, and transformed into competent Escherichia coli as de- 
scribed (28). Plasmid DNA from positive colonies was checked for 
the presence of the G,, coding sequence by restriction mapping, and 
pVL1393/Gq, plasmid DNA from positive clones was amplified and 
purified by centrifugation through  a CsCl gradient (28). To construct 
the expression vector for Gllm, pVL1392 (identical to pVL1393, except 
the polycloning site is in an inverted orientation) was cleaved with 
EcoRI and SmaI. The GI,, cDNA was then cleaved with XhoI and 
filled in with the Klenow fragment of DNA polymerase to yield a 
linearized fragment with a  blunt end. This DNA was cleaved with 
EcoRI to yield a 1.2-kilobase fragment that was purified by  gel 
electrophoresis. The recovered GI,, and pVL1392 fragments were 
ligated and transformed as described above. 
Preparation of Virus and Expression of Recombinant Proteins  in 
Sf9 Cells-Virus encoding rG,, or  rGll, was generated as described 
previously (30). Purified pVL1393/Gq, or pVL1392/Gll, was mixed 
with linearized AcRP23-LacZ virus and transfected (using lipofectin; 
Bethesda Research Laboratories) into a monolayer culture of Sf9 
cells grown in IPL-41 medium. Following initial infection (overnight), 
the medium was replaced, and recombinant virus was amplified for 
2-3 days. Recombinant virus was then plaque-purified as described 
(29). Purified virus was amplified and medium was saved as high titer 
stock. The remaining monolayer of cells was collected and screened 
by Western blotting with appropriate antisera (see below) for the 
presence of expressed recombinant G, subunits. 
Sf9 Cell Culture-Stock cultures of Sf9 cells (50 ml) were  grown in 
suspension in IPL-41 medium (GIBCO) containing 1% Pluronic F68, 
10%  fetal calf serum (heat-inactivated), fungizone, and gentamicin. 
Large scale cultures (8-12 X 1 liter) were grown in IPL-41 medium 
containing 1% fetal calf serum, 1% lipid mix (GIBCO), gentamicin, 
and fungizone. Cells were maintained in room air at 27 "C with 
constant shaking (125 rpm). Generally, cells were seeded at a density 
of 0.5 X lo6 cells/ml and allowed to multiply for 3 days to 4-6 X lo6 
cells/ml before subsequent passage. 
Measurement of Phospholipase C Actiuity-In general, measure- 
ment of phospholipase C activity was as described previously (22); 
the final assay volume  was  60  pl. Substrate was provided as mixed 
phospholipid vesicles containing PIP, (Sigma) and phosphatidyleth- 
anolamine (Sigma) in  a  ratio of 1: lO with 5,000-10,000 cpm of [3H] 
PIP, (Du Pont-New England Nuclear)  per assay. The final concen- 
tration of PIP, was usually 50 p~ (3,000 pmol) or 75 p~ (4,500 pmol) 
unless otherwise stated. Assays were performed in a final buffer 
containing 50 mM sodium Hepes (pH 7.2), 3 mM EGTA, 0.2 mM 
EDTA, 0.83 mM MgCl,,  20 mM NaCl, 30 mM KCl, 1 mM dithiothreitol, 
0.1 mg/ml ultrapure albumin (bovine), 0.16% sodium cholate, and 1.5 
mM CaCl, (to yield approximately 150 nM free Ca2+). 
To perform the assay, four solutions containing the reaction com- 
ponents were prepared separately: 1) G, subunit mix (10 pl/assay); 
2) phosphatidylethano1amine:PIPz lipid mix (20 pl/assay); 3) PLC 
mix (20 pl/assay); and 4) Ca2+ mix (10 &assay). G, subunits were 
first  activated  in incubation buffer 1 (50 mM sodium Hepes (pH 7.2), 
1 mM EDTA, 3 mM EGTA, 5 mM MgC12, 2 mM dithiothreitol, 100 
mM NaC1, and 1% sodium cholate) with 1 mM GTPrS for 1 h at 
30 "C (unless otherwise stated)  and  then stored  on ice. This solution 
contained G, subunits at a  concentration six times higher than  that 
desired in the final assay. Appropriate amounts of lipids (stored  in 
chloroform at -20 "C) were dried under nitrogen at room temperature 
prior to sonication in incubation buffer 2 (50 mM sodium Hepes (pH 
7.2), 3 mM EGTA, 1 mM dithiothreitol, 80 mM KC1). PLC was also 
prepared in incubation buffer 2 containing bovine serum albumin (1 
mg/ml) and, when appropriate, GTPrS (0-3 mM). Ca2+ mix was 
prepared as a  9 mM solution of CaC12 in incubation buffer 2. Before 
assay, 10 pl of G, mix  was added to each tube on ice,  followed  by 10 
r l  of Ca2+ mix. The lipid and PLC  solutions were then added together 
(20  pl of each),  and tubes were transferred to a 30 "C water bath for 
the indicated times. Assays  were terminated by the addition of  200 pl 
of 10% trichloroacetic acid. Tubes were then immediately transferred 
to  an ice bath, followed by the addition of 100 p1 of bovine serum 
albumin (10 mg/ml). Centrifugation at 2,000 X g for 10 min separated 
unhydrolyzed [3H]PIP2  (pellet) from [3H]InsP3  (supernatant). Radio- 
activity in the supernatant was measured by liquid scintillation 
counting. With 50 p~ PIP,  as substrate, the assay was linear for 10 
min at 30 "C; assays were usually run for 3-5 min. In most cases PLC 
activity is expressed as pmol of InsP3/min/ng PLC. To quantify 
purification of G, subunits (see Tables I and 11), PLC activity is 
expressed as pmol of InsPs/min/mg of protein sample containing 
rG,, or rGll,; 2.9 ng of partially purified bovine brain PLC-pl was 
used in these assays. Purified recombinant PLC-01 (see below)  was 
used for other experiments. 
Purification of rG,,, rGI1,, and Endogenous G,,-like Activity from 
Sf9 Cells-Starting material for purification was derived from 12- 
liter  cultures of Sf9 cells infected with 2-5 plaque-forming units/cell 
of either rG,, or rGI1, viruses; cells were also infected with approxi- 
mately equal numbers of virions encoding G protein p2 and 72  
subunits (31). Endogenous G,,-like activity (Sf9 GqJ was purified 
from cells infected with only 02 and 72  viruses. Cells were harvested 
by centrifugation (750 X g),  and pellets were suspended in 400  ml  of 
ice-cold lysis buffer consisting of buffer A  containing 25 mM NaC1, 
10 mM NaF, 30 p~ AlC13, and a mixture of protease inhibitors (0.02 
mg/ml phenylmethylsulfonyl fluoride, 0.03  mg/ml leupeptin, 0.02  mg/ 
ml l-chloro-3-tosylamido-7-amino-2-heptanone, 0.02 mg/ml L-l-to- 
sylamido-2-phenylethyl chloromethyl ketone, and 0.03 mg/ml lima 
bean trypsin  inhibitor). (Buffer A is 50 mM sodium Hepes, pH 7.2, 1 
mM EDTA, 3 mM EGTA, 5 mM MgCl,, 3 mM dithiothreitol, and 0.1 
mM GDP.)  The cell suspension was subjected to nitrogen cavitation 
(Parr bomb) at 500 p.s.i. for 45 min at 4 "C. Cell lysates were then 
centrifuged at 500 X g for 10 min to remove intact cells and nuclei. 
Supernatants were centrifuged at 100,000 X g for 30 min, and  the 
membrane pellets derived therefrom were suspended in 300 ml of 
lysis buffer with a Dounce homogenizer (20 strokes). The membranes 
were finally frozen in liquid nitrogen and stored at -80 "C. For 
purification of recombinant G  proteins, membranes were thawed and 
diluted to 5 mg  of protein/ml with buffer A  containing fresh protease 
inhibitors and  then extracted by the addition of sodium cholate to a 
final concentration of 1% with constant stirring for 60-90 min at 
4 "C. The extracted membranes were centrifuged at 100,000 X g for 
30 min, and 300  ml of supernatant (cholate extract) was collected. 
Phenyl-Sepharose Hydrophobic  Chromatography-A column of 
phenyl-Sepharose CL-4B (200 ml; Pharmacia LKB Biotechnology 
Inc.) was washed with equilibration buffer (buffer A  containing 10 
mM NaF, 30 p~ A1C13, protease inhibitors, 400 mM NaC1, and 0.25% 
sodium cholate). The cholate extract (300 ml) was diluted with 900 
ml of buffer A  containing 575 mM NaC1, 10 mM NaF, 30 p M  AlC13, 
and protease  inhibitors and loaded onto  the column. The resin was 
washed with 300  ml  of equilibration buffer (without AI%), and protein 
was eluted from the column in 25-ml fractions using a 1,500-ml linear 
gradient of equilibration buffer (without AlF;) containing descending 
concentrations of NaCl (400-0 mM) and ascending concentrations of 
sodium cholate (0.25-1.5%). Column fractions were assayed for their 
capacity to activate  partially purified PLC-01 from bovine brain (32, 
33) and for their specific immunoreactivity (antiserum W082 for rG, 
(34), B825 for rGllm, and 2811 for Sf9 Gqa; see below). Immunoreactive 
fractions (generally fractions 22-28)  were  pooled, concentrated to 10 
ml by ultrafiltration, and diluted with 90  ml  of Mono Q equilibration 
buffer (buffer A  containing 0.1 mM GDP, protease inhibitors, and 1% 
octyl glucoside). This solution was concentrated to 20 ml and was 
loaded directly onto a Mono Q column. 
Mono QAnion Exchange Chromatography-A 10-ml Mono Q anion 
exchange column for FPLC (Pharmacia) was equilibrated with 5 
volumes of Mono Q equilibration buffer (buffer A containing 1% 
octyl glucoside). The sample was loaded under pressure at a flow rate 
of 0.5 ml/min. The column was washed with an additional 10 ml of 
Mono Q equilibration buffer, and bound protein was eluted in 50 3- 
ml fractions using a  linear gradient of NaCl (25-300 mM for rGlle; 
25-400 mM for rGq,). The concentration of NaCl was then increased 
to 1,000 mM over an additional 10 fractions (fraction 60) and held 
constant  to fraction 65. Fractions were assayed for  specific immuno- 
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Recombinant G,, and G11, 14369 
reactivity, as well as their capacity to activate PLC-(31, and peak 
fractions were pooled (typically 25-30 ml) and loaded onto a By- 
agarose column. 
&-Agarose Affinity Chromatography-By-Agarose affinity resin (5 
ml; Ref. 19) was equilibrated with 20 ml of buffer B (buffer A 
containing 100 mM NaCI, 10 mM NaF, 30 p M  AlCb, and 0.2% Lubrol). 
To facilitate dissociation of residual from G, subunits, 10 mM 
NaF  and 30 p~ AIC1, (final  concentrations) were added to  the sample, 
which  was incubated at 22 "C for 30 min. The By-agarose was added 
to  the sample and mixed for an additional 30 min at  22 "C. EDTA 
(20 mM final) was then added directly to  the sample to chelate M e  
and promote binding of 01 to  the affinity resin. After mixing overnight 
a t  4 "C, the slurry was transferred to a  10-ml disposable column (Bio- 
Rad); the flow-through was collected and passed again over the packed 
resin. The column was washed at 4 "C with 15 column volumes 
(collected as 5-ml fractions) of buffer A containing 0.2% Lubrol, 
followed by 15 column volumes of buffer C (buffer A  containing 0.1% 
Lubrol and 400 mM NaCI) and 3 column volumes of buffer D (buffer 
A containing 0.2% sodium cholate and 100 mM NaCI). All nonspecif- 
ically bound protein appeared to wash off the resin under these 
conditions. The column was then warmed to 22 "C, and specifically 
bound protein was eluted (collected at  4 'C) by the addition of 5 
column volumes of buffer E (buffer A  containing 100 mM NaCl and 
1% sodium cholate). To ensure that all 01 subunits were eluted from 
the column, the resin was washed further with 5 column volumes of 
buffer F (buffer A  containing 100 mM NaCI, 1% sodium cholate, 10 
mM NaF, 30 p~ AICI,) followed by 5 column volumes of buffer G 
(buffer A  containing 100 mM NaCI, 1% sodium cholate, 10 mM NaF, 
30 p~ AlC13, and 50 mM MgCI2). Fractions were assayed for both 
specific immunoreactivity and  their capacity to activate PLC-Dl; they 
were also stained with silver nitrate after SDS-polyacrylamide gel 
electrophoresis. Fractions containing Lubrol could not be assayed 
directly because of the detergent's marked capacity to inhibit  PLC. 
Peak fractions were frozen in liquid nitrogen and stored at  -80 "C. 
Measurement of f5SJGTPyS Binding to &,,-Purified rG,, was 
stored  in buffer E containing 100 p M  GDP. To remove free nucleotide, 
samples of rGqs were thawed and gel filtered by centrifugation. 
Disposable columns (10 ml; Bio-Rad)  containing 2 ml of G-50 resin 
were equilibrated with buffer E without GDP  and spun at 500 X g for 
4 min at 4 "C. Samples containing rG,, were applied to  the columns 
and spun again exactly as described. Recovered rG, was then incu- 
bated in buffer C  containing 200 p M  GTPyS (12,000 pmol/60 pl) and 
tracer  amounts of [35S]GTPyS (1000-1500 cpm/pmol). Binding pro- 
ceeded for various times at 30 "C. At the times indicated, 60-pl 
samples were  gel filtered by centrifugation; the flow-through contain- 
ing GTPyS-bound rG,, was collected, and  the amount of bound [35S] 
GTPyS was quantified by liquid scintillation counting. Recoveries of 
rG,, following  gel filtration were monitored by the capacity of rG,, 
(activated with GTPyS) to stimulate PLC-Bl before and after gel 
filtration. Recoveries of rG,, after two consecutive gel filtrations 
approximated 12%. Accounting for the loss of  rG,, during gel filtra- 
tion, the fractional occupancy (i.e. the molar ratio of bound GTPyS 
to rGqJ was estimated to be 0.6. The fractional binding of GTPyS  to 
rG,, was also evaluated by a second method. rG, was reconstituted 
with purified recombinant type 1 muscarinic cholinergic receptor and 
brain By in lipid vesicles as described previously (35); carbachol was 
added to stimulate binding of [35S]GTPyS  to a  determined  stoichi- 
ometry. The capacity of this activated rG,, to stimulate  PLC-01 was 
compared with that of known amounts of  rG,, (determined by protein 
assays), which had been activated with unlabeled GTPyS. Based on 
this comparison, the fractional binding of GTPyS  to purified rG,, 
appeared to approach 1. Efforts to  quantitate  GTPyS binding to rG,, 
with filter binding assays were unsuccessful because of unidentified 
technical constraints. 
Antisera-Rabbit anti-G,, serum W082  was raised to a  synthetic 
19-amino acid peptide representing an  internal sequence (amino acids 
115-133) unique to G, (34).  Rabbit  anti-Gll, serum B825 was raised 
to a synthetic 20-amino acid peptide representing an internal se- 
quence (amino acids 114-133) unique to G,,,. Rabbit anti-Gsa./llm 
serum 2811 was raised to a  synthetic 15-amino acid peptide repre- 
senting the carboxyl terminus shared by G, and GI1,, Methods for 
generation of these  antisera have been described (34). 
Miscellaneous Procedures-Reconstitution of cyc- S49 cell mem- 
branes with G, subunits was performed as described previously (36). 
SDS-polyacrylamide gel electrophoresis of proteins was performed as 
described by Laemmli (37);  protein  concentrations were determined 
by staining with Amido Black (38). Staining of protein with silver 
nitrate following SDS-polyacrylamide gel electrophoresis was per- 
formed as described by Wray et al. (39); immunodetection of proteins 
after Western  blotting was performed as described by Mumby et al. 
(40) using the ECL chemiluminescence detection system (Amersham 
Gorp.). Other  proteins were purified as described bovine brain 
Gqa/lla (19, 22); recombinant PLC-81 and recombinant PLC-B2  from 
HeLa cells (25); and PLC-p3 (32,41),  PLC-y1(33),  and PLG-61  from 
brain  (42). rGiml, rGiaZ, rGia3, rGoo(A), rGsacs,, and rG,, (purified from 
E. coli) were kindly provided by Drs. M. E. Linder (University of 
Texas  Southwestern Medical Center) and Patrick Casey (Duke Uni- 
versity), and purified bovine brain By was kindly provided by Ethan 
Lee (University of Texas Southwestern Medical Center). 
RESULTS 
Expression of Gqa and Gl1,-1nitial efforts to synthesize G,, 
in  bacterial expression systems failed. Although immunoreac- 
tive recombinant  protein was detectable in cell lysates, the 
concentration was modest, and  all soluble recombinant pro- 
tein was aggregated and inactive. We subsequently expressed 
rG,, and rGll, in Sf9 cells using recombinant baculovirus. 
Although the concentration of expressed protein was again 
low (estimated to be 0.05% and 0.01% for G, and rGll,, 
respectively, of detergent-extractable membrane protein), 
some portion of the expressed material had the capacity to 
stimulate brain PLC-p1. Based on electrophoresis and im- 
munostaining, rGll, was expressed as  a single protein with an 
apparent molecular mass of 42 kDa. In contrast, rG,, was 
visualized as a pair of proteins with apparent molecular 
masses of  42 and 43 kDa. The  latter observation is presumably 
the result of unexpectedly efficient reading of the altered 
polyhedron initiator codon contained upstream of the inserted 
G,, sequence in the original pVL1393 expression vector. If a 
particular sequence is in-frame with this altered start site, 
current expression of a slightly longer polyhedron fusion 
protein along with the normal protein is reported to be a 
common problem (43). 
Initial  studies were designed to determine what fraction of 
expressed recombinant  protein was active and soluble (Fig. 
1). When G,, was expressed alone, the majority of the im- 
munoreactive material was cytosolic; however, gel filtration 
revealed that most of the protein was inactive and aggregated 
(Fig. 1). Although much less immunoreactivity was associated 
with the membrane fraction, activity (capacity to activate 
PLC-p1) was roughly equal in the cytosol and membrane 
extracts.  Attempts to purify the soluble rG,, were unsuccessful 
because of further aggregation and loss of activity. To circum- 
vent this problem, rG,, was coexpressed with other  G protein 
subunits: p2 (rp2)  and 7 2  (1-72) (31). Under these conditions, 
the majority of the active rG,, was associated with membranes 
and was not aggregated after  extraction with sodium cholate 
(Fig. 1); most of the G, that remained in the cytosol was 
aggregated and inactive (Fig. 1). To generate material for 
purification, rG,, and rGI1, were coexpressed with rp2 and 
ry2 to produce a  heterotrimer. Maximal levels of expressed 
protein were observed 48-60 h  after infection with the  three 
viruses. 
Purification of rG,, rGl1, and Endogenous Sf9 G,,-Cho- 
late  extracts of membranes from triply infected Sf9 cells (12- 
liter  cultures) were used as  the  starting material for purifica- 
tion. However, uninfected, lacZ-infected, and lacZ plus rp2/ 
ry2-infected Sf9 cells possess significant amounts of PLC- 
activating material because of the presence of endogenous 
G,,-like proteins (Sf9 G,,). This activity accounts for perhaps 
10-20%  of the initial  total value in preparations of G,, and 
up to 40% of the initial  total with Gll,. Sf9 G,, was readily 
recognized  by antiserum 2811. rG,,, rGlla,  and Sf9 G,, were 
each purified by monitoring specific immunoreactivity and 
the capacity of GTPyS-activated  protein to stimulate purified 
brain PLC-pl in reconstitution assays. A representative pu- 
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14370 Recombinant Gq, and Glln 
Fraction Number 
FIG. 1. Effect of expression  of G protein By subunits on  the 
activity and distribution of rG,, in Sf9 cells. Sf9 cells were 
infected either with virus encoding rG,, alone (left,  top and bottom 
panels) or with different viruses encoding G,,, &, and y2 subunits 
(right, top and bottompanels). Cytosol and cholate extracts of mem- 
branes were isolated as described under “Materials and Methods.” 
Membrane extracts (top, left and right paneb) and cytosol (bottom, 
left and right panels) were chromatographed  on an AcA-34  gel filtra- 
tion column in the presence of 10 mM NaF, 10 mM MgC12, and 30 MM 
AIC13, and individual fractions were assayed for their capacity to 
stimulate PLC-P1 (2.9 ng). Column fractions were also tested for 
immunoreactivity with anti-G,, antiserum (W082) (see associated 
autoradiograms). V, marks the void volume of the column, and VT 
marks the  total volume. The lines marking the peak fractions of PLC 
activity correspond to  the underlined immunoreactive  fractions.  PLC- 
P activity in this  and all  subsequent figures is expressed as pmol of 
InsPl/min/ng of PLC-8. 
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FIG. 2. Phenyl-Sepharose  hydrophobic  chromatography of 
rG,,. Cholate extracts from a  12-liter preparation of Sf9 cells infected 
simultaneously with viruses encoding G,,, p2, and 7 2  subunits were 
chromatographed on  a  phenyl-Sepharose column. Individual column 
fractions were assayed for their capacity to  stimulate PLC-01 (2.9 
ng) and for their  immunoreactivity with anti-G,, antiserum (W082). 
rification of rG,, is shown in Figs. 2, 3 (top),  and 4. rGqa, 
rGll,, and Sf9 G,, were each purified similarly with  a  three- 
step procedure involving hydrophobic chromatography 
(phenyl-Sepharose; Fig. 2), anion exchange chromatography 
(Mono Q; Fig. 3), and  affinity  chromatography (By-agarose; 
Fig. 4). The elution of GI1, from a Mono Q anion exchange 
column is shown in Fig. 3 (bottom), which also shows the 
resolution of rGI1, from Sf9 G,,. In  contrast to  the  situation 
with rGll,, rG,, was expressed at sufficiently high levels to 
obscure the activity associated with Sf9 G,, on  the Mono Q 
column (Fig. 3, top) .  Because of this, only the active  fractions 
of rG,, with the earliest  elution  times were pooled to ensure 
complete resolution of rG,, from Sf9 G,,. Although most of 
the endogenous and recombinant By eluted before the a 
subunits  on  the Mono Q column, residual By was resolved 
from free rG,, during subsequent affinity chromatography 
using &agarose (Fig. 4). All final pools of rGqn, rGlla, and 
Sf9 G,, could be activated by either GTPrS or AlF; plus 
Mg2+ (Fig. 4 and  data  not shown). The purification schemes 
for rG,, and rGll, are summarized  in  Tables  I and 11, respec- 
tively. Because of interference from endogenous Sf9 G,, dur- 
ing the early  steps of purification and  the negative influence 
of high concentrations of By on  the capacity of  rG,, and rGll, 
to activate PLC-(31, accurate  assessment of fold purification 
is not possible. A 12-liter culture of infected cells yielded 
approximately 15 pg of pure rGIl, in the peak fraction, 
whereas a  similar  preparation of  rG,, yielded 125 pg  of protein. 
SDS-polyacrylamide gel electrophoresis of purified brain 
Gqa/lln (19, 22), rGqa, rGll,, and Sf9 G,, is shown in Fig. 5. 
Following treatment with N-ethylmaleimide, all  proteins mi- 
grate with an apparent molecular mass of approximately 40- 
42 kDa. As discussed above, rG,, was expressed as two pro- 
teins  with molecular masses of approximately 42 kDa (75% 
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FIG. 3. Mono Q anion  exchange  chromatography of rG,,  and 
rGll,. Fractions containing rG, protein from the phenyl-Sepharose 
column were chromatographed on a Mono Q FPLC column as de- 
scribed under  “Materials and Methods.” Top  panel, rG,,; bottom panel, 
rGll,. Individual fractions were assayed for their capacity to stimulate 
PLC-Dl and for their immunoreactivity with selective antisera. W082 
is an anti-G,, antiserum, B825 is an anti-GI1, antiserum,  and 2811 is 
an anti-G,, and GI1, antiserum that recognizes the carboxyl terminus 
of both CY chains. 
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FIG. 4. By-Agarose affinity chromatography of rG,. Frac- 
tions containing rG,, from the Mono Q column were pooled and 
chromatographed  on By-agarose as described under  "Materials  and 
Methods."  Individual  column fractions were assayed for  their  capacity 
to stimulate  PLC-81 (2.9 ng),  and  proteins were  visualized by staining 
with silver nitrate (see  associated  gel). Samples were activated  with 
either 1 mM GTPyS  or AICln (30 p ~ ) ,  NaF  (10 mM), MgCI, (5 mM), 
and  GDP (0.1 mM). 
TABLE I 
Purification of ffi,, 
Step Volume  Protein pLc activitv Stimulated 
ml nmol InsPJ mg minlmg protein 
Cholate  extract 1,200 1,630 9.8" 
Phenyl-Sepharose 175 119 24" 
Mono Q 18 11.2 104 
&-Agarose 5 0.125 14,600 
a PLC  activity includes that  stimulated by endogenous (Sf9 cell) 
PLC-activating G proteins. 
TABLE I1
Purification of rGll, 
Volume  Protein pLc activitv Stimulated 
ml mg nmol InsP31 minlmg protein 
Cholate  extract 1,200 1,520 13" 
Phenyl-Sepharose 150 228 73" 
Mono Q 18 5.1 1,070 
&-Agarose 3 0.01.5 49,300 
' PLC  activity  includes  that  stimulated by endogenous (Sf9 cell) 
PLC-activating G proteins. 
of the total) and 43 kDa (25%). Endogenous Sf9 G,, also 
appears  to  contain two proteins. All proteins were judged to 
be more than 90% pure based on silver staining. rG,, con- 
tained a  minor 40-kDa contaminant  that is likely an endoge- 
nous Gi,,,-like protein, based on its immunoreactivity  with  a 
nonspecific G, antiserum  (data  not shown). rGI1, contained a 
minor,  unidentified 42.5-kDa contaminant. Antiserum W082, 
which was generated  with  a synthetic peptide  corresponding 
to  an  internal sequence specific for G,, (34), recognizes brain 
Gqn/lln, rG,,, and Sf9 G,, but fails to recognize rGll,. Anti- 
serum B825  was raised against a synthetic peptide represent- 
ing an internal sequence specific for GI1, (overlapping the 
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FIG. 5. SDS-polyacrylamide  gel  electrophoresis and immu- 
noblot analysis of purified bovine  brain Gq,,ll, (bGq,,ll), rGq,, 
rGlla, and endogenous Sf9 cell  PLC-activating  protelns 
(Sf9Q). Approximately 75 ng of each  preparation was treated with 
N-ethylmaleimide and then resolved on 9.5% polyacrylamide gels. 
The left panel is  a  silver stain of the  proteins,  and  the right panels 
are immunoblots using the indicated antisera. Sf9Q refers to the 
endogenous  PLC-activating G,,-like protein(s); bn,/ll refers to brain- 
derived native GqIlI,,. 
= 120 A z t  t e  tc + GTPys 
minutes 
FIG. 6. Activation of rG,, and rGI1, by GTPrS. Panel A, 
concentration  dependence  for  activation of  rG,, and rGI1, by GTPyS. 
Assay  buffer (0) or buffer containing  either  10 nM rG,, (0) or 10 nM 
rGI1, (0) was incubated with the  indicated  concentrations of GTPyS 
for 1 h a t  30 "C; samples were then tested for their capacity to 
stimulate  rPLC-Pl (1 ng). Panel B, time course for  activation of rG,, 
by GTPyS. Assay  buffer (0) or buffer containing  10 nM  rG,, (0) was 
incubated  with 1 mM GTPyS for the  indicated  times a t  30 "C; samples 
were then  tested  for  their  capacity to  stimulate  rPLC-Pl (1 pg). Panel 
C, deactivation of rGqq. rG,,, (10 nM) was activated with 0.05 mM 
GTPyS for 1 h a t  30 "C. At time = 0, samples were incubated at  
30 "C with either 0.05 mM GTPyS (0) or 0.05 mM GTPyS plus 5 
mM GDP (0). Aliquots were tested for their capacity to stimulate 
rPLC-Pl (1 ng) a t   the  indicated  times. 
homologous region of GqJ; this antiserum recognizes both 
rG,, and rGI1, but fails to recognize Sf9 G,,, Antiserum 2811, 
raised against a synthetic peptide corresponding to the 15 
carboxyl-terminal amino acid residues that  are  shared by G,, 
and  Gllo, recognizes all cy subunits in the four preparations. 
Characterization of Purified rG,, and rGll,-Both rG,, and 
rGI1, are activated by GTPyS, although high concentrations 
of the nucleotide are required = 30 p M )  (Fig. 6A); 
maximal  activation is achieved with 1 mM GTPyS. Despite 
the high concentration of nucleotide, complete  activation of 
rG,,, by GTPyS occurred only after 60 min of incubation; 
activated  protein is stable for a t  least  an additional 60 min at  
30 "C (Fig. 6B). Once achieved, activation of G,, by GTPyS 
is reversed only slowly (by the addition of excess GDP) (Fig. 
6C). 
In keeping with the high concentration of GTPyS required 
to activate rG,, and rGll,, it was technically difficult to 
measure the binding of ["S]GTPyS to rG,,. For  reasons that 
are unclear,  assays based on the  adsorption of the  protein- 
nucleotide complex to filters were not successful. However, 
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the complex of [35S]GTPyS with rG,, could be isolated by  gel 
filtration. Binding was detected in  the presence of concentra- 
tions of GTPyS which are capable of activating G,,; data 
obtained using 200 WM [35S]GTPyS  are shown in Fig. 7. The 
rate of binding of this concentration of GTPyS to rG,, 
appeared to be slightly slower than  that for activation of the 
protein by 1 mM GTPyS,  but they were clearly comparable. 
Because of limiting amounts of protein and  the very large 
quantities of isotope required to perform these experiments, 
detailed characterization of the binding reaction was not 
undertaken. Nevertheless, using two independent measures 
(see “Materials and Methods”), the molar ratio of bound 
nucleotide to rG,, ( i e .  fractional occupancy) was estimated 
to range from 0.6 to 1.0. Measurement of GTPyS binding to 
rGll, was not attempted because of the small amount of 
protein available. 
rG,, and rGll, were purified, in part, based on  their capacity 
to stimulate partially purified PLC-(31 from bovine brain. 
Studies were carried out to determine the relative capacity of 
rGll,, rGq,, bovine brain Gqapla, and other rG, subunits to 
activate purified forms of PLC-(3, including recombinant 
PLC-pl, recombinant PLC-(32, and native PLC-(33. Pertussis 
toxin blocks hormonal activation of phospholipase C  in  cer- 
tain tissues, suggesting the involvement of a Gi- or Go-like 
protein in those  pathways  (11,12). As such, purified pertussis 
toxin-sensitive, GTPyS-activated a subunits  (rGhl, rGiaz, 
rGia3, and rG,,*; purified from E. coli)  were tested for their 
capacity to stimulate rPLC-(31,  rPLC-(32, and  native PLC-(33; 
other E. coli-derived G, subunits that are unaffected by per- 
tussis toxin and the brain (37 subunit complex were also tested 
(Table 111). rGqa, rGll,, and  brain  Gqa/lla e ch clearly activates 
all  three isoforms of PLC-8; in contrast,  the other a subunits 
fail to elicit any response (Table 111). Purified bovine brain 
(37 also stimulates the activity of all  three  types of PLC-(3 
(Table 111; see also Refs. 41, 44-49). The capacity of  rG,, and 
rGll, to stimulate  PLC is apparently specific for the PLC-(3 
isoforms; that is, no activated a subunit  stimulates purified 
bovine brain PLC-y1 or PLC-61 (Table  IV). To address issues 
of specificity more completely, the relative capacity of rGsa(s), 
rGqu, and rGll, to activate adenylylcyclase in cyc- S49 cell 
membranes was also compared. rG,, and rGll, both fail to 
100 
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FIG. 7. Binding of [’‘SlGTPrS to rGqa. rG,, (4.5 pmol/6O p1) 
was incubated at 30 “C for the indicated times with 200 pM [35s] 
GTPyS (1,500 cpm/pmol). Samples containing rG,, (0) or  buffer (0) 
were  rapidly filtered by centrifugation through a 1.4-ml G-50 column. 
Fractional occupancy (the molar ratio of GTPrS bound to rGqJ  was 
estimated to range  from 0.6 to 1.0 (see “Materials and Methods”). 
G,, and G11, 
TABLE I11 
Effect of G protein subunits on phospholipase C-P  isoforms 
Addition Concentration rPLC-@l rPLC-82 Brain PLC-B3 
activity activity activity 
pmol InsP3 f min/ng PLC 
10 nM 
10 nM 
10 nM 
100 nM 
100 nM 
100 nM 
100 nM 
100 nM 
100 nM 
3 PM 
17 
246 
305 
332 
20 
18 
21 
21 
21 
25 
65 
3.5 
22 
40 
39 
3.4 
2.9 
2.9 
3.6 
4.0 
6.2 
45 
95 
246 
259 
2.6 
6.9 
3.6 
4.0 
5.7 
5.7 
4.5 
35 
TABLE IV 
Lack of stimulation of PLC-71 and PLC-61 by G protein subunits 
Addition Concentration Brain PLC-61 Brain PLC-yl 
activity activity 
30 nM 
30 nM 
30 nM 
100 nM 
100 nM 
100 nM 
100 nM 
100 nM 
100 nM 
3 PM 
0 
50 nM 
150 nM 
10 pM 
100 pM 
1 mM 
pmol InsP, f min/ng PLC 
14.1 6.5 
11.0  8.0 
8.8 8.1 
9.1 7.6 
6.9  8.2 
8.3  7.0 
7.1  7.5 
8.8 7.2 
7.0  7.3 
10.0 9.1 
16.6  9.4 
2.0  0.5 
3.7  3.5 
14.1 6.5 
369 12.7 
372 14.0 
365 11.4 
activate adenylylcyclase under conditions in which rG.,(.) is 
clearly effective (data  not  shown). rG, and rGI1, also fail to 
inhibit rG.,(,)-mediated stimulation of adenylylcyclase. Simi- 
lar results were obtained with recombinant types I and I1 
adenylylcyclases. 
The relative capacities of rGll,, rG,, and Sf9 G,, to activate 
purified isozymes of PLC-(3 are shown in Fig. 8. Both  rGll, 
and rG,, activate each of the  three forms of PLC-(3; the two 
a subunits display essentially identical properties. In contrast, 
Sf9 G,, stimulates only weakly. rG, and rGll, stimulate  PLC- 
(31 and PLC-(33 to a much greater extent  than they do PLC- 
(32 (Fig. 8, A and B; see also Ref. 50). Under the assay 
conditions employed, rG,, and rGll, display similar or slightly 
lower half-maximal concentrations for activation of rPLC-(31 
and PLC-(33 (-2 nM) than they do for rPLC-(32 ( -5  nM) (Fig. 
8). 
Both rG,, and rGll, are at least  as  potent  as purified bovine 
brain Gq,/ll, as activators of rPLC-(31 (Fig. 9). It should be 
noted, however, that  the potencies of these proteins  are  sen- 
sitive to  the choice of detergent used in  the assay; that is, in 
the presence of 0.16% (final) octyl glucoside, the for 
activation of PLC-(31  by G, and (37 subunits is 3-10-fold  lower 
than  that observed in the presence of 0.16% cholate (data  not 
shown; see Ref. 41). Nevertheless, the rank order for G, 
subunit-mediated  activation of rPLC-P isozymes, as well as 
the  extent of activation, is preserved in  the presence of octyl 
glucoside (data  not shown). 
Studies were also carried out to  test whether (3y subunits 
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FIG. 8. Activation of PLC-8 isoforms by rGqa, rGlla, and Sf9 
G,. Panel A,  rG, (O), rGll, (0), and Sf9 G,, (Sf9Q; 0) were each 
activated for 1 h with 1 mM GTP-yS at  30 "C prior to reconstitution 
with rPLC-81 (1 ng) (top  panel), rPLC-82 (8 ng) (middle panel), or 
rat brain  PLC-83 (0.32 ng) (bottom panel). Panel B,  comparison of 
the activation of PLC-pl (O), PLC-82 (W), and  PLC-p3 (A) by  rGq,. 
G protein was activated with 1 mM GTP-yS for 1 h at 30 "C prior to 
reconstitution with rPLC-01 (1 ng). Data shown (panels A and B )  
are duplicate determinations from a single experiment and  are rep- 
resentative of at least two such experiments. The  data in panel E and 
those from additional  experiments were subjected to a  nonlinear  least 
squares fit to  the four-parameter logistic equation Y = [A/1 + (C/ 
X ) B ) ]  + D, and  the derived mean ECm f S.E. values for activation of 
PLCp isoforms by rG, were as follows: 2.0 f 0.4 nM (n = 6) for 
rPLC-pl; 4.7 k 0.7 nM (n = 3) for rPLC-82; and 2.5 f 0.9 nM (n = 
3) for brain PLC-p3. 
influence activation of rPLC-Pl or  rPLC-P2 by  rG,, or rGll, 
(Fig. 10). Purified brain 0-y subunits  stimulate  all  three iso- 
forms of PLC-#l (Table 111). In  the case of rPLC-Pl,  activated 
rG,, and rGI1, each stimulates the enzyme to a much greater 
extent  and  at lower concentrations than does brain P-y (Fig. 
10, A and B ) ;  levels of stimulation  in the presence of both G, 
and are not additive (Fig. 10, A and B ) .  In the case of 
rPLC-02, B-y subunits  stimulate the enzyme to levels similar 
to those observed with either rG,, or rGll,, but higher con- 
centrations of 0-y than a are required (Fig. 10, C and D). The 
combined effects of  G, and P-y are again not additive. 
- log  [a1 M 
FIG. 9. Activation of rPLC-81 by rG,,, rGlla, and bovine 
brain G,,,II~. rG, (W), rGI1, (A), and brain Gqm,llm (0) were activated 
with 1 mM GTPyS for 1 h a t  30  "C prior to reconstitution with rPLC- 
81 (1 ng). 
rPLC$l 
[By] PM [ra] nM 
FIG. 10. Effects of rG,,, rGlla, and G protein 87 subunits on 
rPLC-81 and rPLC-82 activities. Panel A ,  the capacity of the 
indicated concentrations of bovine brain 0-y to stimulate rPLC-PI 
was determined in the absence of a subunit (0) or in the presence of 
either 10 nM rG,, (W) or 10 nM rGll, (0). Panel B,  the capacity of 
the indicated concentrations of rG,, (squares) or rGI1, (circles) to 
stimulate  rPLC-61 activity was determined in the absence of P-y (open 
symbols) or  in the presence of 2 p~ bovine brain Py (closed  symbols). 
Panels C and D, the same  experiments were performed with rPLC- 
p2, rather  than rPLC-81. rG,, and rGI1,  were activated with 1 mM 
GTP-yS for 1 h at 30 "C prior to  the assays, and  GTP+ was present 
in all assays at a final concentration of 1 mM. 
DISCUSSION 
Following expression of rG,, and rGI1, in Sf9 cells, modest 
quantities of active protein  can be purified using a  three-step 
procedure; however, unusual measures are required. When 
expressed under conditions that have previously favored syn- 
thesis of active recombinant G, subunits in bacteria  or insect 
cells (18,51-53), rG,, and rGI1, aggregate with loss of activity. 
Only when these subunits are expressed together with G 
protein P and y subunits  are reasonable quantities of active, 
nonaggregated protein generated. Such restrictions compli- 
cate the purification of free CY subunits  and  dictate the use of 
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uncommon reagents (i.e. &agarose and viruses encoding fl  
and y). Nevertheless, if these  reagents  are available, modest 
quantities of pure, active a subunit  can be obtained. 
The observation that purified rG,, and rGI1, stimulate 
purified recombinant isozymes of phospholipase C  both con- 
firms and  extends previous reports using purified components 
from native sources (21-23, 26). Since these  studies involved 
the use of a mixture of native Gum and G,, and/or native 
PLC, the availability of resolved, pure forms of rG,,, rGll,, 
and  PLC isozymes has allowed us to define specific interac- 
tions between these  proteins unambiguously. The major find- 
ings from these studies  can be summarized as follows. 1) rG,, 
and rGll, each regulates the activity of the  three /3 isoforms 
of PLC  but  not PLC-yl or PLC-61. 2) rG,, and rGll, share 
indistinguishable properties for activation of these enzymes. 
3) Of the several G  proteins  tested, only members of the G,, 
subfamily of a subunits  are capable of activating PLC; by can 
also stimulate  PLC-6 activity. 4) The responses of PLC-p2 to 
rG,,, rGlla, and By differ from those of PLC-pl  and PLC-(33. 
5)  In  the absence of receptor, rG, and  rGll, have an unusually 
poor apparent affinity for GTPyS.  6) Recombinant G,, and 
Gll, from Sf9 cells and  native Gq,/lla from bovine brain have 
similar affinities for PLC-@ isoforms and capacities to activate 
the enzymes. 
r G q ,  and  rGI1,  Regulate  the  Activity of the  Three p Isoforms 
of PLC  but  Not  PLC-yl or PLC-61”Despite the relatively 
low sequence homology among the noncatalytic domains of 
PLC-61, PLC-p2, and  PLC-p3 (12, 54), rG,, and rGll, stim- 
ulate the activity of each of the enzymes. Previous reports 
(24,25) indicated that G,, activated  PLC-61 but not PLC-p2. 
The present  results indicate that rG,, and rGll, can indeed 
stimulate rPLC-P2, albeit to a significantly lesser extent  than 
either PLC-01 or PLC-@3 (see also Ref. 50). In addition, 
activation of rPLC-fi2 requires higher concentrations of  rG,, 
and rGI1, than is the case for rPLC-61  and PLC-63. It is clear 
that the concentrations of  G,, used previously (25) were 
insufficient to activate PLC-62. rGqa, rGll,, and by do not 
stimulate PLC-yl and PLC-61, confirming the specificity for 
regulation of the  PLC isoforms by G protein subunits and 
defining differential pathways for regulation of the PLC 
subfamilies. The y subfamily of PLC is regulated by certain 
tyrosine kinase receptors (12, 55), although a role for G 
proteins in this  pathway  cannot be completely ruled out (56). 
To date,  there is no evidence to support the idea of receptor- 
directed regulation of the 6 subfamily of PLC. However, PLC- 
81 seems particularly responsive to Ca2+ (at least under the 
present assay conditions; see Table IV), suggesting that  this 
enzyme may be regulated primarily by changes in cytosolic 
concentrations of  Ca2’. 
rG,, and  rGI1,  Share  Indistinguishable  Properties  for  Acti- 
vation  of PLC-6-rG,, and rGl1, activate the  three isoforms 
of PLC-fl in an indistinguishable manner, suggesting that  the 
two G proteins can serve interchangeably as physiological 
regulators of these enzymes. These observations are reminis- 
cent of the  apparent lack of specificity for activation of cardiac 
K’ channels by  Gia1, Giaz, and Giaa (8, 57). The physiological 
significance of this is not clear. Specificity could exist at  the 
level of receptor-(; protein coupling. However, type 1 musca- 
rinic receptors stimulate guanine nucleotide exchange with 
both G,, and GI1, in reconstitution studies (35). It will be 
important to determine whether various PLC-linked receptors 
demonstrate equal or dissimilar affinities for G,, and Gll,, as 
well as  other members of the G,, family. Alternatively, spec- 
ificity could be dictated by differential tissue  distribution of 
G, subunits  and/or the PLC isoforms. Both rG,, and rGI1, 
are expressed widely in a variety of tissues (13, 34), but little 
information is available as to whether  these two a subunits 
are expressed simultaneously in  the same cells. In the case of 
the enzymes, PLC-(33 and PLC-61 seem to be expressed 
broadly, whereas PLC-62  has  a much more limited distribu- 
tion (41, 50). 
Of  the G Proteins  Tested,  Only  Members of the G,, Subfamily 
of G Protein a Subunits  Are Capable of Activating  PLC”py 
subunits,  but  apparently  not  other a subunits, have the ca- 
pacity to stimulate  PLC-p activity. Other G, subunits, includ- 
ing Gi,1, Gi,z, Gi,3, Goa(*), G,,, and G,,(,, from E. coli, fail to 
activate  any of the PLC isozymes.2 These findings are signif- 
icant, since pertussis  toxin blocks receptor-mediated activa- 
tion of PLC in a limited number of tissues (11, 12), and none 
of the currently identified pertussis  toxin  substrates  can ac- 
tivate the available isoforms of PLC. An unidentified isoform 
of PLC might be regulated by a  pertussis toxin-sensitive a 
subunit, or an undefined toxin-sensitive a subunit could  be 
involved. Alternatively and perhaps most reasonably, this 
pathway could be regulatedprimarily by G protein Py subunits 
liberated in the plasma membrane by activation of appropri- 
ate receptors (see 11, 41,  44-49). Consistent with this idea is 
the finding that Py subunits  stimulate  PLC-p2 to a similar or 
greater extent than either rG,, or rGll,, albeit with lower 
potency (Fig. 10 and Refs.  41,  46). Unlike the situation with 
adenylylcyclase (58),  activation of PLC-6 isoforms by by does 
not require a subunits. 
The Responses of PLC-p2  to G Protein  Subunits  Differ  from 
Those of PLC-Dl and PLC-fl3-PLC-/31 and PLC-/33 are 
stimulated to a much greater extent  than is PLC-/32  by  rG,, 
and rGll,, and slightly lower (2-3-fold) concentrations of  rG,, 
and rGI1, are required to stimulate  PLC-61  and  PLC-63 than 
PLC-p2.  Thus, it is possible that these a subunits preferen- 
tially activate  PLC-p1  and  PLC-63  but do not readily stimu- 
late PLC-62. As discussed above, this scenario is consistent 
with the notion that PLC-62 is regulated significantly by G 
protein By subunits (41, 44-49). 
I n  the  Absence of an  Appropriate Receptor, rG,, and rG11, 
Have  an  Unusually  Poor  Affinity  for  GTPyS-In contrast  to 
most other G, subunits, G, and Gll, have an unusually poor 
apparent affinity for GTPyS in the absence of an appropriate 
agonist-receptor complex (19, 26). Here we demonstrate that 
rG, can  bind GTPyS fairly rapidly (compared with other  G 
protein a subunits) but only in  the presence of high concen- 
trations of nucleotide. Roughly  30 WM concentrations of 
GTPyS  are required to activate G,, or G11, half-maximally. 
Similar values for most other  G  protein a subunits  are in the 
3-10  nM range. The rate of reversal of GTPyS-mediated 
activation of G,, by GDP is slow (although faster than  that 
observed with several other a subunits), suggesting that 
GTPyS does not dissociate rapidly once bound. The simplest 
explanation for these observations is that the kinetics of 
association of GTPyS with rG,, is limited by the rate of 
dissociation of GDP from the protein (as with other  G  protein 
a subunits)  and that  the poor apparent affinity of the nucleo- 
tide for the protein is dictated by an extremely slow rate of 
association. Thus, we envision an occluded nucleotide binding 
A technical point should be raised concerning the  use of E. coli- 
derived (Y subunits. Even though 10-fold higher concentrations of 
these proteins were tested, we cannot rule out the possibility of 
reduced potency of these proteins because they lack certain post- 
translational modifications (e.g. the addition of fatty acids) that may 
be functionally significant (31, 60). Nevertheless, these recombinant 
proteins do activate appropriate effectors (adenylylcyclase, ion chan- 
nels) when used in  the 1-100 nM concentration range. We have also 
determined that myristoylated forms  of recombinant G~=I ,  G a ,  
and Goa(*) derived  from E. coli (1 PM) fail either to stimulate directly 
or to inhibit G,,-directed activation of the three p isoforms of PLC. 
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site, even when the protein is nucleotide-free. Others have 
demonstrated that receptors can influence the association of 
nucleotides with G  protein a subunits (35, 59), in  addition to 
well documented effects of receptor on the  rate of nucleotide 
dissociation. We suggest that such effects are particularly 
marked with G,, and Gll,, resulting  in  a more than 1,000-fold 
increase in the affinity of the proteins for GTPrS in the 
presence of an agonist-receptor complex. Although the phys- 
iological significance of these observations is as obscure as 
the mechanism, the phenomenon appears to make activation 
of these  G  proteins exquisitely dependent on receptor, ensur- 
ing minimal activation of PLC by G,, in  the absence of a 
proper stimulatory ligand. 
Recombinant Forms of Gqa and GI1, Derived from  Sf9 Cells 
and Native Gpa/llu Activate PLC-p Isoforms Similarly-rG,, 
and rGll, obtained from the Sf9 cell expression system have 
similar if not higher apparent  affinities for PLC-p1 than does 
bovine brain Gqn/llu, and the three a subunit preparations 
activate the  three isoforms of PLC-p to similar  extents. In 
contrast,  studies with G., synthesized in E. coli revealed that 
the recombinant protein  had  a 30-fold  lower apparent affinity 
for adenylylcyclase when compared with the native  protein 
(51). G  protein a subunits synthesized in  bacteria lack one or 
more post-translational modifications (51); a subunits derived 
from eukaryotic expression systems are presumably modified 
properly (53,60). Thus,  G  protein a subunits expressed in Sf9 
cells are covalently modified with fatty acids; palmitate is 
incorporated into Gqa, G, and members of the Gi, subfamily, 
whereas myristate is also incorporated  into the Gialoa proteins 
(61). It will  be important to determine if these modifications 
influence the functional  interactions of  G,, and GI1, with the 
plasma membrane or with other  proteins  in the signal trans- 
duction pathway. 
The G,, subfamily consists of at least five members, includ- 
ing G,,, GI,, G14a,  Gx,, and G16a. Whereas G,,, Gll,, and G14a 
are very similar proteins (79% amino acid identity), Gl6, and 
G16, are more distantly related (57 and 58% amino acid 
identity, respectively). G15, and G16, are also distinct in that 
they  are expressed only in hematopoietic cells, whereas G,,, 
Gll,, and G14a are widely distributed. Despite this, G14,, G15,, 
and G16, (synthesized in COS-7 cells) all  activate PLC-p1 and 
PLC-(32 when the phospholipases are  either expressed con- 
currently  or added as purified proteins to membranes contain- 
ing the expressed G, subunit (24, 62). It will be important  to 
define the  extent of functional interactions among these a 
subunits, PLC isoforms, cell surface receptors, and Pr sub- 
units by reconstitution of purified components. Further  stud- 
ies will also be required to determine if members of the G,, 
subfamily activate effectors other  than PLC. 
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